Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
While observational studies consistently link low vitamin D levels to a higher risk of cognitive decline and Alzheimer's disease, interventional trials fail to show that adding supplements slows or prevents cognitive deterioration (240, 241).
Source: Controversial findings and heterogeneity between studies. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Review / evidence synthesis.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Publisher article type: review-article
Source: Publisher publication metadata.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Nutritional intervention targeting muscle-brain axis in dementia continuum: from mechanisms to practice
Review / evidence synthesis · Frontiers in Nutrition · 2026
Original publication title
Nutritional intervention targeting muscle-brain axis in dementia continuum: from mechanisms to practice
Copyright © 2026 Topcuoglu, Guler, Gulhan Halil, Hanagasi, Midi, Saka and Saka Topcuoglu.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Rapid aging of global population has led to an attention increasingly focusing on age-related changes in muscle and cognitive functions, specifically the interplay between sarcopenia, frailty and cognitive impairment as the interconnected geriatric syndromes with major health consequences. Despite being the central pathophysiological substrate across these geriatric syndromes, skeletal muscle loss is still insufficiently prioritized as a treatment objective. Incorporating the “malnutrition-sarcopenia-frailty” triad into dementia care is essential for continuity of management, as muscle preservation is fundamental to sustaining cognitive function within an active aging paradigm.
This perspective reframes longevity by shifting emphasis from anticipating frailty to living with strength, valuing added years through resilience rather than decline. This narrative review, prepared by experts in neurology and geriatrics, explores the muscle-brain crosstalk and highlights skeletal muscle loss as a modifiable target for nutritional intervention in cognitive impairment and dementia. In conclusion, given the bidirectional links between malnutrition, sarcopenia, frailty, and cognitive decline through shared aging mechanisms, a high protein oral nutritional supplement [enriched with beta-hydroxy-beta-methylbutyrate (HMB)] and vitamin D emerges as a practical, compliant strategy to support muscle health and potentially contribute to preservation of cognitive health in older adults with or at risk of dementia, although direct evidence for cognitive benefit remains limited.
Authors’ abstract
Rapid aging of global population has led to an attention increasingly focusing on age-related changes in muscle and cognitive functions, specifically the interplay between sarcopenia, frailty and cognitive impairment as the interconnected geriatric syndromes with major health consequences. Despite being the central pathophysiological substrate across these geriatric syndromes, skeletal muscle loss is still insufficiently prioritized as a treatment objective. Incorporating the “malnutrition-sarcopenia-frailty” triad into dementia care is essential for continuity of management, as muscle preservation is fundamental to sustaining cognitive function within an active aging paradigm.
This perspective reframes longevity by shifting emphasis from anticipating frailty to living with strength, valuing added years through resilience rather than decline. This narrative review, prepared by experts in neurology and geriatrics, explores the muscle-brain crosstalk and highlights skeletal muscle loss as a modifiable target for nutritional intervention in cognitive impairment and dementia. In conclusion, given the bidirectional links between malnutrition, sarcopenia, frailty, and cognitive decline through shared aging mechanisms, a high protein oral nutritional supplement [enriched with beta-hydroxy-beta-methylbutyrate (HMB)] and vitamin D emerges as a practical, compliant strategy to support muscle health and potentially contribute to preservation of cognitive health in older adults with or at risk of dementia, although direct evidence for cognitive benefit remains limited.
Publication and source details
Original title: Nutritional intervention targeting muscle-brain axis in dementia continuum: from mechanisms to practice
Mehmet Akif Topcuoglu; Ayse Guler; Meltem Gulhan Halil; Hasmet Hanagasi; Ipek Midi; Bulent Saka; Esen Saka Topcuoglu
Frontiers in Nutrition · 2026
* Correspondence: Mehmet Akif Topcuoglu, mat@hacettepe.edu.trORCID: Meltem Gulhan Halil orcid.org/0000-0001-7597-8140; Bulent Saka orcid.org/0000-0001-5404-5579; Esen Saka Topcuoglu orcid.org/0000-0002-6291-0312
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T21:23:23.534887+00:00
DOI: 10.3389/fnut.2026.1966218 · PMC13663878